Literature DB >> 28835464

Mapping and predicting mortality from systemic sclerosis.

Muriel Elhai1, Christophe Meune2, Marouane Boubaya3, Jérôme Avouac1, Eric Hachulla4, Alexandra Balbir-Gurman5, Gabriela Riemekasten6, Paolo Airò7, Beatriz Joven8, Serena Vettori9, Franco Cozzi10, Susanne Ullman11, László Czirják12, Mohammed Tikly13, Ulf Müller-Ladner14, Paola Caramaschi15, Oliver Distler16, Florenzo Iannone17, Lidia P Ananieva18, Roger Hesselstrand19, Radim Becvar20, Armando Gabrielli21, Nemanja Damjanov22, Maria J Salvador23, Valeria Riccieri24, Carina Mihai25, Gabriella Szücs26, Ulrich A Walker27, Nicolas Hunzelmann28, Duska Martinovic29, Vanessa Smith30, Carolina de Souza Müller31, Carlo Maurizio Montecucco32, Daniela Opris33, Francesca Ingegnoli34, Panayiotis G Vlachoyiannopoulos35, Bojana Stamenkovic36, Edoardo Rosato37, Stefan Heitmann38, Jörg H W Distler39, Thierry Zenone40, Matthias Seidel41, Alessandra Vacca42, Ellen De Langhe43, Srdan Novak44, Maurizio Cutolo45, Luc Mouthon46, Jörg Henes47, Carlo Chizzolini48, Carlos Alberto von Mühlen49, Kamal Solanki50, Simona Rednic51, Lisa Stamp52, Branimir Anic53, Vera Ortiz Santamaria54, Maria De Santis55, Sule Yavuz56, Walter Alberto Sifuentes-Giraldo57, Emmanuel Chatelus58, Jiri Stork59, Jacob van Laar60, Esthela Loyo61, Paloma García de la Peña Lefebvre62, Kilian Eyerich63, Vanesa Cosentino64, Juan Jose Alegre-Sancho65, Otylia Kowal-Bielecka66, Grégoire Rey67, Marco Matucci-Cerinic68, Yannick Allanore1.   

Abstract

OBJECTIVES: To determine the causes of death and risk factors in systemic sclerosis (SSc).
METHODS: Between 2000 and 2011, we examined the death certificates of all French patients with SSc to determine causes of death. Then we examined causes of death and developed a score associated with all-cause mortality from the international European Scleroderma Trials and Research (EUSTAR) database. Candidate prognostic factors were tested by Cox proportional hazards regression model by single variable analysis, followed by a multiple variable model stratified by centres. The bootstrapping technique was used for internal validation.
RESULTS: We identified 2719 French certificates of deaths related to SSc, mainly from cardiac (31%) and respiratory (18%) causes, and an increase in SSc-specific mortality over time. Over a median follow-up of 2.3 years, 1072 (9.6%) of 11 193 patients from the EUSTAR sample died, from cardiac disease in 27% and respiratory causes in 17%. By multiple variable analysis, a risk score was developed, which accurately predicted the 3-year mortality, with an area under the curve of 0.82. The 3-year survival of patients in the upper quartile was 53%, in contrast with 98% in the first quartile.
CONCLUSION: Combining two complementary and detailed databases enabled the collection of an unprecedented 3700 deaths, revealing the major contribution of the cardiopulmonary system to SSc mortality. We also developed a robust score to risk-stratify these patients and estimate their 3-year survival. With the emergence of new therapies, these important observations should help caregivers plan and refine the monitoring and management to prolong these patients' survival. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cardiovascular disease; epidemiology; pulmonary fibrosis; systemic sclerosis

Mesh:

Year:  2017        PMID: 28835464     DOI: 10.1136/annrheumdis-2017-211448

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  122 in total

1.  The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.

Authors:  Aryeh Fischer; Jörg Distler
Journal:  Clin Rheumatol       Date:  2019-08-19       Impact factor: 2.980

3.  Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Authors:  Perrine Guillaume-Jugnot; Manuela Badoglio; Myriam Labopin; Louis Terriou; Ibrahim Yakoub-Agha; Thierry Martin; Bruno Lioure; Zora Marjanovic; Didier Blaise; Stéphanie Nguyen; Gregory Pugnet; Anne Huynh; Christophe Deligny; Christophe Seinturier; Frédéric Garban; Laure Swiader; Jacques-Olivier Bay; Thorsten Braun; Régis Peffault de Latour; Marie Thérèse Rubio; Dominique Farge
Journal:  Clin Rheumatol       Date:  2019-01-21       Impact factor: 2.980

Review 4.  Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; Loukia Koutsogeorgopoulou; Theodoros Dimitroulas; Vasiliki Vartela; Angelos Rigopoulos; Michel Noutsias; Genovefa Kolovou
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

5.  Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.

Authors:  Vivek Nagaraja; Marco Matucci-Cerinic; Daniel E Furst; Masataka Kuwana; Yannick Allanore; Christopher P Denton; Ganesh Raghu; Vallerie Mclaughlin; Panduranga S Rao; James R Seibold; John D Pauling; Michael L Whitfield; Dinesh Khanna
Journal:  Arthritis Rheumatol       Date:  2020-05-18       Impact factor: 10.995

6.  Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).

Authors:  Nicolas Hunzelmann; Stephan Rosenkranz; Michael Huntgeburth; Johannes Kießling; Gerrit Weimann; Verena Wilberg; Soundos Saleh
Journal:  Clin Drug Investig       Date:  2018-11       Impact factor: 2.859

7.  Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis.

Authors:  Thais Rohde Pavan; Markus Bredemeier; Vanessa Hax; Karina Gatz Capobianco; Rafael da Silva Mendonça Chakr; Ricardo Machado Xavier
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

8.  Body composition and bone status in relation to microvascular damage in systemic sclerosis patients.

Authors:  V Smith; M Cutolo; S Paolino; E Gotelli; F Goegan; A Casabella; G Ferrari; M Patane; M Albertelli; F Gatto; C Pizzorni; F Cattelan; A Sulli
Journal:  J Endocrinol Invest       Date:  2020-05-24       Impact factor: 4.256

Review 9.  Detection and classification of systemic sclerosis-related interstitial lung disease: a review.

Authors:  Daniel J DeMizio; Elana J Bernstein
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

10.  Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial.

Authors:  G S R S N K Naidu; Shefali Khanna Sharma; M B Adarsh; Varun Dhir; Anindita Sinha; Sahajal Dhooria; Sanjay Jain
Journal:  Rheumatol Int       Date:  2019-12-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.